utologous chondrocyte implantation (ACI) and mosaicplasty are both claimed to be successful for the repair of defects of the articular cartilage of the knee but there has been no comparative study of the two methods. A total of 100 patients with a mean age of 31.3 years (16 to 49) and with a symptomatic lesion of the articular cartilage in the knee which was suitable for cartilage repair was randomised to undergo either ACI or mosaicplasty; 58 patients had ACI and 42 mosaicplasty. Most lesions were post-traumatic and the mean size of the defect was 4.66 cm 2 . The mean duration of symptoms was 7.2 years and the mean number of previous operations, excluding arthroscopy, was 1.5. The mean follow-up was 19 months (12 to 26).
A
Autologous chondrocyte implantation (ACI) 1 and mosaicplasty 2 have both been described for repair of symptomatic defects of the articular cartilage in the knee. The results appear to be encouraging, but there are no prospective, randomised, controlled clinical trials which compare the two methods. We have therefore undertaken such a trial to compare mosaicplasty with ACI for the repair of articular defects of the femoral or tibial condyles and the patella. We also report the use of a porcine collagen membrane (chondrogide) to cover the defect in cartilage as an alternative to periosteum.
Patients and Methods
A total of 100 consecutive patients with a mean age of 31.3 years (16 to 49) and with symptomatic lesions of the articular cartilage of the knee was randomised to have either mosaicplasty (42 patients) or ACI (58 patients). There were 57 men and 43 women with a mean age at the time of surgery of 31.6 years (20 to 48) for those who underwent mosaicplasty and 30.9 years (16 to 49) for those who underwent ACI. The mean size of the defect was 4.66 cm 2 (1 to 12.2) with 61 patients having defects in the right knee and 39 in the left. The study was approved by the Joint Research and Ethical Committee of the Royal National Orthopaedic Hospital Trust.
The aetiology and anatomical sites of the defects are shown in Table I . Of the 100 knees, 46 (46%) had post-trau- matic defects, 19 (19%) had osteochondritis dissecans, 14 (14%) had chondromalacia patellae and 21 (21%) had lesions of unknown aetiology which were probably posttraumatic. The lesions were on the medial femoral condyle in 53 knees (53%), the patella in 25 (25%), the lateral femoral condyle in 18 (18%), the trochlea in 3 (3%) and the lateral tibial plateau in one (1%). Two major features were the long duration of symptoms before surgery (mean 7.2 years) and the fact that all but six patients had undergone previous surgical interventions. All had undergone arthroscopy and the mean number of further operations was 1.5 (0 to 4). The mean follow-up period was 19 months (12 to 31).
The primary indication for surgery was persistent pain and reduction in activities. There were a variety of other symptoms including giving-way, catching, locking, and swelling of the knee. Operative technique. Initially, an arthroscopy was carried out. If the lesion was suitable for cartilage grafting, randomisation was undertaken by using random sample numbers in sealed envelopes. The criteria for grafting were an osteochondral or chondral defect of greater than 1 cm in diameter in a joint which was otherwise biomechanically normal and free from inflammatory disease. Patients randomised to mosaicplasty had the procedure under the same general anaesthetic. With both techniques we made an appropriate longitudinal incision over the joint, medial or lateral to the patella, depending on the site of the defect. After exposure and assessment, the articular cartilage at the edge of the defect was cut vertically with a scalpel. Remnants of residual cartilage were removed from the defect and, if there was bleeding, noradrenaline solution was applied to the surface by using a small swab. All patients received prophylactic antibiotics (flucloxacillin and amoxicillin, 0.5 g of each) at the time of surgery and at six and 12 hours postoperatively.
For mosaicplasty, when possible we used large mosaic plugs 4.5 mm in diameter to fill the remaining part of the defect (Fig. 1) . Since positioning of the mosaics was important the plugs were placed slightly prominently in order to allow contact with the opposite articular surface during normal movement. This was to ensure that nutrition was maintained by loading and by the passage of fluid through the articular cartilage. When possible, the plugs were taken from the margins of the trochlea. The slope of the donor articular surface was matched to that to be replaced in the defect. In some patients the plugs came from the margins of the intercondylar notch. At the end of the procedure we moved the joint through a full range of movement to check that the mosaics were stable and satisfactorily placed. Closure was by absorbable sutures and steristrips to the skin, with drainage. Autologous chondrocyte implantation. For ACI the procedure was carried out in two stages. The first stage required arthroscopy and the harvesting of a fragment of articular cartilage, approximately 2 x 1 cm in size from the margin of the trochlea (Fig. 2) . The fragment was of full-thickness Photographs showing the use of mosaicplasty for the repair of an osteochondral defect of the medial femoral condyle. Fig. 2 Arthroscopic appearance of the harvesting of a full-thickness articular cartilage from the margin of the trochlea.
articular cartilage in order to give the maximum yield of cells from the deep zone. After removal through a second portal the fragment underwent enzymic digestion in order to release cells. Culture of the cells was carried out in serum taken from the patient's blood at the time of surgery. Postoperative treatment was routine for the arthroscopy. We undertook the second stage, the arthrotomy, three to five weeks later. After initial preparation (Fig. 3) we covered the defect with a piece of porcine collagen membrane of the appropriate size, or a piece of periosteum taken from the patient's tibia or femur. After careful suturing of the membrane or periosteum to the margins of the defect with 6/0 vicryl and tying as close to the surface of the cartilage as possible (3 to 4 mm intervals), the junction was rendered watertight by the application of fibrin glue. The cultured cells were then delivered behind the membrane with a 1 ml syringe and a fine catheter (Fig. 4) . With the aim of inflating the membrane, but avoiding spillage by excessive pressure, depending on the size of the lesion, we injected between 5 and 10 million cells (mean 5.5) before the final suture and seating with glue. The wound was carefully closed in layers with non-absorbable sutures and without drainage. Rehabilitation. The rehabilitation programme was identical after both operative techniques.
We enclosed the leg in a compression Robert Jones type of bandage, reinforced by plaster-of-Paris backslabs. The leg was rested and elevated for 12 hours and the patient encouraged to exercise the foot and ankle, and to do quadriceps contraction exercises. Movement was not allowed at this stage since it has been observed that early movement may cause detachment of the membrane. Full weight-bearing was encouraged at 24 hours after surgery. This acts as a stimulus to the circulation of the limb and also to fluid exchange of articular cartilage.
At 48 hours we applied a light cylinder cast with the knee in full extension and the patient was discharged, fully weight-bearing but using crutches for support. After removal of the plaster at ten days, the rehabilitation programme allowed the patient to bear weight fully, but they used crutches for six weeks in order to avoid unexpected stresses on the knee. Mobilisation was encouraged, combined with daily physiotherapy for two weeks in order to achieve a full range of movement. At this point, provided that the wound was satisfactory, we encouraged other activities such as swimming, gentle cycling, and rowing exercises in the gym to achieve maximum mobilisation as rapidly as possible. The advice was, however, to avoid impact loading and twisting strains on the knee. At the end of six weeks the patient continued with the exercise programme, and formal physiotherapy if necessary, but returned to work and the normal activities of daily living. At six months, light jogging could commence, but no sporting activity was allowed until 12 months after the operation. Assessment at review. Patients underwent regular assessment throughout the postoperative period and at one year. The clinical assessment was by the modified Cincinatti rating system (Table II) and the Stanmore functional rating system. 3 There was no difference in the results when using either system, and the final results were graded as excellent (>80), good (55 to 79), fair (30 to 45) or poor (<30), based Photograph showing a large (3.5 x 4 cm) defect of the medial condyle of the femur after resection to healthy peripheral cartilage. The black staining is from previous implantation of carbon fibres. on the Cincinatti rating. In clinical terms, patients with excellent and good results had improvement, those with fair results were unchanged and those with poor results were worse than before operation. Arthroscopy and biopsy with a 2.5 mm diameter Jamshidi needle was repeated at one year in the ACI group. The repair was observed and assessed using the International Cartilage Research Society (ICRS) grading system. Biopsy was not always possible, particularly in the patellofemoral joint which can be inaccessible when the patella is stable. The biopsies were all examined by a specialist osteoarticular pathologist (JP). Statistical analysis. Statistical comparison of outcome scores between the groups was by the Mann-Whitney U test for non-parametric data. A p value <0.05 was taken to be statistically significant.
Results
Clinical. Overall, of 58 patients with lesions treated by ACI, 51 (88%) had an excellent or good result (Table III) compared with 29 of 42 (69%) treated by mosaicplasty (p = 0.277). Table IV also shows that at one year, of the 24 lesions of the medial femoral condyle treated by ACI, 21 had an excellent or good result (88%) compared with 21 of 29 (74%) treated by mosaicplasty (p = 0.032). This difference was significant.
For lesions of the lateral femoral condyle, 92% had an excellent or good result after ACI compared with 40% after mosaicplasty (p = 0.182). For patellar lesions, 85% had an excellent or good result after ACI compared with 60% after mosaicplasty (p = 0.076) ( Table IV) .
The numbers of lesions of the trochlea and lateral tibial plateau were too small for statistical analysis. An excellent arthroscopic appearance of a mosaicplasty of the trochlea at one year which shows the plugs to be well incorporated into the fibrocartilage repair tissue of the defect. Arthroscopic appearance of mosaicplasty of the medial femoral condyle at two years which shows fibrillation of the osteochondral plugs and incomplete filling of the spaces between them. These data show that the overall results were better for ACI, but not significantly different. Those for the medial femoral condyle were statistically significant. This may be a site-specific effect but, more likely, it is due to the smaller numbers for sites other than the medial femoral condyle. Arthroscopic. Arthroscopy at one year revealed ICRS grades of 1 or 2 in 31 of 37 patients (82%). After mosaicplasty only eight of 23 patients (34%) had a grade-1 or grade-2 repair (Table V) . This difference was significant (p < 0.01).
Mosaicplasty seemed to be very satisfactory in some patients (Fig. 5 ) but in others there was incomplete healing of the spaces between the grafts and fibrillation of the repair tissue (Fig. 6) . At one year most ACI patients showed filling of the defects with good incorporation. This resulted in a high ICRS score, although in 50% of patients the tissue was relatively soft on probing when compared with the surrounding cartilage.
Of the 19 biopsies taken from the ACI patients at one year, three were from the patella and 16 from the femoral condyle. Hyaline cartilage of normal appearance was found in seven patients after ACI with normal structure of the cartilage under polarised light and cells in lacunae which were bonded to the calcified zone. S100 immunostaining for S100 protein confirmed the presence of cartilage cells (Fig.  7) . Seven patients showed both hyaline cartilage and fibrocartilage and five patients fibrocartilage, albeit well-bonded to bone. One of the ACI grafts which showed mixed hyaline and fibrocartilage at one year has shown hyaline cartilage alone at the two-year biopsy. This suggests that grafts can mature to hyaline cartilage up to two years after surgery as has been suggested by Petersen et al. 1 Poor. The seven poor results were all in the mosaicplasty group. In four the plugs were in situ, but the tissue between Figure 7c -Immunostaining for S100 protein (peroxidase) from a biopsy at one year. The brown nuclear staining confirms the presence of cartilage cells in the tissue (S100 x34). them had not become covered with continuous fibrous tissue (Fig. 6) . In three patients the plugs had disintegrated altogether. In one patient the area of the mosaicplasty had remained reasonably intact, but the articular cartilage at the margins of the defect had broken down to expose subchondral bone.
Complications. Most patients completed the rehabilitation programme without complications. Three were slow to mobilise and required manipulation under anaesthesia. One of these required arthroscopy and arthrolysis in order to mobilise the knee. One patient developed calf-vein thrombosis at ten weeks and was treated by anticoagulants. There was one case of superficial infection which settled rapidly with a course of oral antibiotics for five days.
Discussion
Our randomised, controlled, clinical trial with a mean follow-up of 1.7 years has shown that both mosaicplasty and ACI give encouraging clinical results after a mean period of one year, although mosaicplasty appeared to deteriorate with time. Arthroscopic examination showed a marked difference with only fair or poor results after mosaicplasty in 66% of patients. None of the five patients who underwent a mosaicplasty of the patella had a good arthroscopic result. This is almost certainly due to the differing thicknesses of donor and recipient articular cartilage which can make healing and incorporation of the patellar articular cartilage and bone unlikely. Moreover, the structural orientation of the articular cartilage matrix in the donor and the recipient is different, and presumably not adapted for the same stress resistance. For normal nutrition of articular cartilage, compression and movement on the opposing articular cartilage surface are required. No matter how meticulous the technique, this is difficult and probably impossible to achieve for all the plugs. Finally, the dependence of the repair on the formation of fibrocartilage between the plugs leads to an intrinsic weakness in the repair system. For the patients who had received ACI, although at one year the defects were often dissimilar to the surrounding articular cartilage, there was no clinical or arthroscopic deterioration during the period of follow-up, which was up to two years in seven patients.
A number of important points have been raised in this study which require clarification by continued observation. The first is the possible damage created by the harvesting of articular cartilage from the healthy area of the joint on the margin of the trochlea. Arthroscopy at one year after mosaicplasty showed, without exception, covering of the donor defect with a film of fibrocartilage. There is a similar healing process with harvesting for ACI, but the surface is not hyaline articular cartilage. Secondly, the assessment of healthy articular cartilage in the joint at the time of the grafting operation is only judged by the colour and texture of the articular cartilage at operation and by confirmation at subsequent histological examination. Adequate resection of abnormal articular cartilage is important so that the graft cells can bond to healthy articular cartilage. If the excision is inadequate there is arthroscopic evidence that the articular cartilage will continue to break down at the edge of the graft. It is important to be radical rather than conservative in this excision. If, however, there are a few isolated cracks in the articular cartilage at a distance from the main defect, it is reasonable to drill these with a fine Kirschner wire in order to stimulate some repair by fibrocartilage repair in the cracks.
Excision of subchondral bone and the provocation of bleeding are controversial. Since the earliest grafting operations it was thought that bleeding may wash cells out of the defect or that the blood would be harmful to the grafted cells. 4 Often the area to be grafted has proliferative bone in the defect which has been provoked by procedures such as drilling or microfracture and abrasion. This bone is so prominent that it must be trimmed before grafting so that a smooth subchondral contour is achieved. It is our standard practice to prevent any bleeding by the use of noradrenaline solution. We have been unable to demonstrate any difference between those patients in whom bleeding occurred at surgery and those in whom it did not. If the amount of bone which is removed is only 1 to 2 mm in thickness the cancellous bone spaces are not completely opened up and bleeding is restricted.
Also important is the question of a bone defect which may be up to 1 cm deep underneath the articular cartilage. Petersen (personal communication) has stated that a defect of up to 7 or 8 mm may fill spontaneously with new bone beneath the cartilage graft. We have seen this in the trochlea of one patient and it is therefore our present practice, unless there is a defect of 1 cm depth or more, not to graft this area with cancellous bone before the cell graft (Fig. 8) .
The periosteal covering of the defect is also controversial. It is claimed by Petersen et al 1 that the periosteum not only provides a membrane which prevents leakage of the implanted cells, but that it also provides growth factors and cells which may contribute to the process of graft repair. In our study we used periosteum in six patients as a covering membrane, and a porcine collagen membrane (chondrogide), in 46. We were unable to demonstrate any difference in the repair process. We therefore doubt that the periosteum is necessary. Furthermore, it can hypertrophy and cause symptoms after operation which may require arthroscopy and shaving of the periosteum. In the series of Petersen et al, 1 however, the follow-up was from two to nine years, and therefore it could be that periosteum is more satisfactory in long-term repair.
The insertion of many sutures into the surrounding articular cartilage at the margin of the defect has caused concern since this may damage the articular cartilage. We have been unable to find any definite evidence of such damage. It appears that a greater problem is the inadequate excision of articular cartilage which can lead to breakdown at the margins of the graft. It is important, however, particularly with deep defects, to ensure that the sutures are placed as close as possible to the surface. If this is not done it may inhibit the growth of the graft up to the surface. This is a particular problem on the patella (Fig. 9 ). The suture technique should ensure, as far as possible, edge-to-edge contact between the periosteum or membrane and the articular cartilage, especially on the patella, where the cartilage can be 7 to 8 mm deep.
The number of cells which are required for repair of a defect is unknown. In our study we used a mean of 5.5 million cells. The actual number implanted is many times that which would normally be present in the defect. We presume that many of these cells die. This is a matter which requires further experimentation.
A further concern is the effect of storage and freezing on the cells. Since the early studies of Smith, 5 there has been concern about the viability of cells which have been frozen and then transplanted. Unpublished results from a larger study in the rabbit have clearly shown that freezing of cells reduces their efficacy as transplants. 6 This is the only prospective, controlled, clinical trial of mosaicplasty and ACI. While the ultimate test will be the longer-term results, it appears that the optimistic report of Petersen et al, 1 is justified for ACI. The long-term durability of mosaicplasty appears to be doubtful for biological and technical reasons.
In summary, our study has shown that both mosaicplasty and ACI give encouraging clinical results after a mean period of one year, but that mosaicplasty appears to deteriorate with time. No patient with a mosaicplasty of the patella had a good arthroscopic result which is almost certainly due to the widely differing thicknesses of the donor and recipient articular cartilage. This may make healing and ultimate incorporation of the graft extremely unlikely. As a consequence, we consider that mosaicplasty of the patella is contraindicated. Indeed, mosaicplasty may be of only temporary value in other sites in the knee. Its main use Arthroscopic appearance of a healed patellar defect at one year after ACI. The original cartilage is seen on the left and the repair tissue is seen, incompletely filling the gap. This is almost certainly due to the obstruction of the growth of the cartilage repair tissue to full height by the membrane which was sutured to the base of the intact cartilage rather than the superficial zone.
appears to be in the treatment of small defects up to 1 cm in diameter.
Our patients had a high number of excellent and good results and are being followed further. In addition, the arthroscopic results indicate more complete healing in patients who had ACI although at one year the articular cartilage graft was soft in some patients. We now plan to undertake a further arthroscopy at two years since there is some evidence from Petersen et al 1 that if a graft is satisfactory at two years, it will remain so for up to ten years.
The use of chondrogide porcine membrane as an alternative to periosteum has proved to be satisfactory in our study and we could detect no difference in the healing with chondrogide compared with periosteum. Moreover, the clinical and arthroscopic results are comparable with other studies which have used periosteum as a graft-covering material. Further work is required to clarify the issues raised by these findings. There is definite evidence, however, that ACI is valuable for selected patients in that it gives healing of hyaline cartilage in chondral and osteochondral defects. It can also dramatically reduce the symptoms of pain and disability. The continued use of mosaicplasty, however, appears to be dubious.
